scopolamine oral
Selected indexed studies
- Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. (Ther Drug Monit, 2005) [PMID:16175141]
- Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. (Pharm Res, 1989) [PMID:2762223]
- Effects of oral scopolamine on human stimulus evaluation. (Psychopharmacology (Berl), 1985) [PMID:3925478]
_Worker-drafted node — pending editorial review._
Connections
scopolamine oral is a side effect of
Sources
- Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. (2005) pubmed
- Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. (1989) pubmed
- Effects of oral scopolamine on human stimulus evaluation. (1985) pubmed
- Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study. (2012) pubmed
- Oral scopolamine hydrobromide solution as an antisialagogic agent in dentistry. (1987) pubmed
- The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance. (1986) pubmed
- Scopolamine Use in the Perioperative Patient: A Systematic Review. (2018) pubmed
- The effect of scopolamine on memory and attention: a systematic review and meta-analysis. (2025) pubmed
- Scopolamine bioavailability in combined oral and transdermal delivery. (2001) pubmed
- Scopolamine Treatment and Adaptation to Airsickness. (2020) pubmed